Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04165317
Title Study of PF-06801591 in Combination With Bacillus Calmette-Guerin (BCG) in Participants With High-Risk Non-Muscle Invasive Bladder Cancer. (B8011006)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Pfizer

bladder urothelial carcinoma


BCG solution + PF-06801591

BCG solution

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL

No variant requirements are available.